Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NICOLAS: Nivolumab + Chemo-radiotherapy in Stage III NSCLC
NCT02434081Phase 2Completed
- Sponsor
- ETOP IBCSG Partners Foundation
- Start
- Nov 2015
- Primary completion
- Feb 2020
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of nivolumab in non-small cell lung carcinoma (NSCLC), sponsored by ETOP IBCSG Partners Foundation. Started Nov 2015; status: completed.
02
Drugs
03
Conditions
non-small cell lung carcinoma (NSCLC)
Beyond the preview
Go deeper on NCT02434081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02434081.